MMRF 25 Voices - Dr. Ajai Chari

When Dr. Ajai Chari started out in #myeloma 20 years ago, patient survival rates were 1-3 years. Thanks to the unprecedented rate of drug approvals, we now have many therapeutic options for patients. Dr. Chari speaks about a patient considering hospice who he convinced to try one last treatment - and describes how that patient is now in his deepest remission in years. Dr. Chari knows the job is not yet finished; we must continue to work extremely hard to see curative therapies for myeloma. And he credits the MMRF with playing a central role in convening all stakeholders to accelerate drug discovery to get us there. #25Voices #MMRF25